These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32451342)

  • 1. Daridorexant: A new medication for insomnia in older adults?
    Molano JRV
    Neurology; 2020 May; 94(21):e2287-e2289. PubMed ID: 32451342
    [No Abstract]   [Full Text] [Related]  

  • 2. Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder.
    Zammit G; Dauvilliers Y; Pain S; Sebök Kinter D; Mansour Y; Kunz D
    Neurology; 2020 May; 94(21):e2222-e2232. PubMed ID: 32341187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.
    Dauvilliers Y; Zammit G; Fietze I; Mayleben D; Seboek Kinter D; Pain S; Hedner J
    Ann Neurol; 2020 Mar; 87(3):347-356. PubMed ID: 31953863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study.
    Fernandes M; Placidi F; Mercuri NB; Liguori C
    Neurol Sci; 2024 Jul; 45(7):3443-3448. PubMed ID: 38280086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials.
    Jiang F; Li H; Chen Y; Lu H; Ni J; Chen G
    Medicine (Baltimore); 2023 Feb; 102(7):e32754. PubMed ID: 36800596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response of daridorexant in insomnia disorder: An analysis of Phase 2 and 3 studies.
    Luyet PP; McCall WV; Bassetti CLA; Braunstein G; Laurent J; Olivieri A; Hedner J
    Sleep Med; 2024 Sep; 121():315-325. PubMed ID: 39047305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daridorexant: First Approval.
    Markham A
    Drugs; 2022 Apr; 82(5):601-607. PubMed ID: 35298826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suvorexant approved for insomnia.
    Traynor K
    Am J Health Syst Pharm; 2014 Sep; 71(18):1524. PubMed ID: 25174007
    [No Abstract]   [Full Text] [Related]  

  • 9. Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia-Reply to Palagini et al.
    Nobile B; Courtet P
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37428089
    [No Abstract]   [Full Text] [Related]  

  • 10. Daridorexant for insomnia disorder.
    Spiegelhalder K; Feige B; Riemann D; Kyle SD
    Lancet Neurol; 2022 Feb; 21(2):104-105. PubMed ID: 35065026
    [No Abstract]   [Full Text] [Related]  

  • 11. Suvorexant for Adults with Insomnia.
    Scarff JR
    J S C Med Assoc; 2015; 111(1):28-9. PubMed ID: 27124984
    [No Abstract]   [Full Text] [Related]  

  • 12. Suvorexant: something new for sleep?
    Reddy A; Puvvada SC; Kommisetti S; El-Mallakh RS; Lippmann S
    Acta Neuropsychiatr; 2015 Feb; 27(1):53-5. PubMed ID: 25397996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia].
    Tanaka Y; Aoki I; Ishine T; Renger JJ; Winrow CJ; Hisada S
    Nihon Yakurigaku Zasshi; 2016 Jul; 148(1):46-56. PubMed ID: 27430679
    [No Abstract]   [Full Text] [Related]  

  • 14. First-in-class insomnia drug on the brink of approval nod.
    Osborne R
    Nat Rev Drug Discov; 2013 Jul; 12(7):492-3. PubMed ID: 23812257
    [No Abstract]   [Full Text] [Related]  

  • 15. Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report.
    Tabata H; Kuriyama A; Yamao F; Kitaguchi H; Shindo K
    J Clin Sleep Med; 2017 May; 13(5):759-760. PubMed ID: 28212694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suvorexant (Belsomra) for Insomnia.
    Gauld AR
    Am Fam Physician; 2016 Jun; 93(12):1016-20. PubMed ID: 27304771
    [No Abstract]   [Full Text] [Related]  

  • 17. Suvorexant (Belsomra) for insomnia.
    Med Lett Drugs Ther; 2015 Mar; 57(1463):29-31. PubMed ID: 25719996
    [No Abstract]   [Full Text] [Related]  

  • 18. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia.
    Patel KV; Aspesi AV; Evoy KE
    Ann Pharmacother; 2015 Apr; 49(4):477-83. PubMed ID: 25667197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of the dual orexin receptor antagonist daridorexant.
    Treiber A; Delahaye S; Weigel A; Aeänismaa P; Gatfield J; Seeland S
    Xenobiotica; 2023 Mar; 53(3):173-183. PubMed ID: 36809238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin receptor antagonists: a new treatment for insomnia?
    Riemann D; Spiegelhalder K
    Lancet Neurol; 2014 May; 13(5):441-3. PubMed ID: 24680373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.